Loratadine and Alecensa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loratadine (loratadine) and Alecensa (alectinib hydrochloride). Common drug interactions include diarrhoea among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Loratadine and Alecensa. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

What is Alecensa?

Alecensa has active ingredients of alectinib hydrochloride. eHealthMe is studying from 5,132 Alecensa users. Check the latest studies of Alecensa.

On Aug, 04, 2026

17 people who take Loratadine and Alecensa together, and have interactions are studied.

Loratadine and Alecensa drug interactions.

What are the common drug interactions of Loratadine and Alecensa, by gender? *:

female:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Oedema (fluid collection in tissue)
Rash
Death
Constipation
Pyrexia (fever)
Accident
Hyperlipidaemia (presence of excess lipids in the blood)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

male:

Death
Arthralgia (joint pain)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Peripheral swelling
Productive cough
Skin disorder (skin disease)
Skin lesion
Thrombocytopenia (decrease of platelets in blood)
Vitamin b12 deficiency
Anaemia macrocytic (a macrocytic class of anaemia)

What are the common drug interactions of Loratadine and Alecensa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Peripheral swelling

50-59:

Oedema (fluid collection in tissue)
Rash
Pyrexia (fever)

60+:

Death
Diarrhoea
Blood alkaline phosphatase increased
Chest pain
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Contusion (a type of hematoma of tissue in which capillaries)
Deafness
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Headache (pain in head)
Insomnia (sleeplessness)

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 41.18%
Lung Cancer - Non-Small Cell (lung cancer): 7 people, 41.18%
Oedema (fluid collection in tissue): 2 people, 11.76%
Swelling: 1 person, 5.88%
Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
Neoplasm Malignant (cancer tumour): 1 person, 5.88%
Metastases To Lung (cancer spreads to lung): 1 person, 5.88%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 1 person, 5.88%
Joint Pain: 1 person, 5.88%
Insomnia (sleeplessness): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and Alecensa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously